申请人:Allergan, Inc.
公开号:US04810804A1
公开(公告)日:1989-03-07
Retinoid-like activity is exhibited by compounds of the formula ##STR1## where X is S, O or NR.sub.1 where R.sub.1 is hydrogen or lower alkyl; n is 0-5; R is H or lower alkyl and A is H, --COOH or a pharmaceutically acceptable salt, ester or amide thereof, --CH.sub.2 OH or an ether or ester derivative thereof, or --CHO or an acetal derivative thereof, or --COR.sub.2 or a ketal derivative thereof where R.sub.2 is --(CH.sub.2).sub.m CH.sub.3 where m is 0-4; or a pharmaceutically acceptable salt.
化合物的公式为##STR1##,其中X为S、O或NR.sub.1,其中R.sub.1为氢或较低烷基;n为0-5;R为H或较低烷基,A为H、--COOH或其药学上可接受的盐、酯或酰胺,--CH.sub.2 OH或其醚或酯衍生物,或--CHO或其缩醛衍生物,或--COR.sub.2或其缩酮衍生物,其中R.sub.2为--(CH.sub.2).sub.m CH.sub.3,其中m为0-4;或其药学上可接受的盐,表现出类视视黄醇活性。